Comorbidity, age and overall survival in patients with advanced pancreatic cancer – results from NCIC CTG PA.3: a phase III trial of gemcitabine plus erlotinib or placebo - Vickers, M M; Powell, E D; Asmis, T R (European journal of cancer (Oxford, England: 1990), 2012)
et al.